Moreover, the results of the LDH assay further showed that STS promoted cellular death of papillary thyroid cancer cells, and the death level of papillary thyroid cancer cells knocked down by BRAF V600E was further aggravated by STS treatment (Figure 2G). This evidence concerns the gene BRAF and thyroid gland papillary carcinoma.